Page last updated: 2024-10-21

sk&f 82958 and Parkinson Disease

sk&f 82958 has been researched along with Parkinson Disease in 5 studies

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tratnjek, L1
Glavan, G1
Višnjar, T1
Živin, M1
Gilmore, JH1
Watts, VJ1
Lawler, CP1
Noll, EP1
Nichols, DE1
Mailman, RB1
Akai, T1
Ozawa, M1
Yamaguchi, M1
Mizuta, E1
Kuno, S1
Hanson, GR1
Keefe, KA1
Hassani, OK1
Féger, J1

Other Studies

5 other studies available for sk&f 82958 and Parkinson Disease

ArticleYear
Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation.
    The European journal of neuroscience, 2016, Volume: 43, Issue:7

    Topics: Animals; Axonal Transport; Benzazepines; Corpus Striatum; Dopamine Agonists; Dopaminergic Neurons; M

2016
"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications.
    Neuropharmacology, 1995, Volume: 34, Issue:5

    Topics: Adenylyl Cyclases; Autopsy; Benzazepines; Binding, Competitive; Caudate Nucleus; Dopamine; Dopamine

1995
Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 273, Issue:1

    Topics: Animals; Benzazepines; Dopamine Agonists; Drug Therapy, Combination; Lisuride; Macaca fascicularis;

1995
Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway.
    Brain research. Molecular brain research, 1999, Mar-20, Volume: 66, Issue:1-2

    Topics: Animals; Benzazepines; Caudate Nucleus; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonist

1999
Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
    Neuroscience, 1999, Volume: 92, Issue:2

    Topics: Adrenergic Agents; Animals; Apomorphine; Benzazepines; Dopamine Agonists; Male; Oxidopamine; Parkins

1999